Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $16.9 Million - $25.6 Million
-269,221 Reduced 91.97%
23,500 $2.21 Million
Q1 2023

May 15, 2023

BUY
$47.19 - $70.77 $13.2 Million - $19.9 Million
280,721 Added 2339.34%
292,721 $19.8 Million
Q4 2022

Feb 14, 2023

SELL
$30.35 - $53.15 $5.05 Million - $8.84 Million
-166,385 Reduced 93.27%
12,000 $594,000
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $2.4 Million - $3.7 Million
74,975 Added 72.5%
178,385 $5.8 Million
Q2 2022

Aug 15, 2022

BUY
$35.61 - $76.23 $3.68 Million - $7.88 Million
103,410 New
103,410 $4.07 Million
Q2 2021

Aug 16, 2021

SELL
$93.66 - $139.27 $9.42 Million - $14 Million
-100,582 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$116.57 - $155.01 $11.7 Million - $15.6 Million
100,582 New
100,582 $13.3 Million
Q2 2020

Aug 14, 2020

SELL
$55.75 - $92.75 $2.68 Million - $4.45 Million
-47,999 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$37.9 - $104.44 $1.82 Million - $5.01 Million
47,999 New
47,999 $2.78 Million
Q4 2019

Feb 14, 2020

SELL
$77.66 - $99.74 $485,685 - $623,773
-6,254 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$90.37 - $122.49 $3.89 Million - $5.28 Million
-43,095 Reduced 87.33%
6,254 $565,000
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $28.2 Million - $37.2 Million
-315,432 Reduced 86.47%
49,349 $5.83 Million
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $22.6 Million - $35.2 Million
364,781 New
364,781 $31.6 Million
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $3.71 Million - $6.18 Million
-76,727 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$37.84 - $69.96 $1.7 Million - $3.14 Million
-44,818 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$39.82 - $57.53 $1.41 Million - $2.04 Million
35,452 Added 378.52%
44,818 $1.81 Million
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $435,425 - $566,736
9,366
9,366 $492,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.